Daniel Havlichek

933 total citations
42 papers, 650 citations indexed

About

Daniel Havlichek is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, Daniel Havlichek has authored 42 papers receiving a total of 650 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 14 papers in Epidemiology and 10 papers in Pharmacology. Recurrent topics in Daniel Havlichek's work include Antibiotics Pharmacokinetics and Efficacy (9 papers), Antimicrobial Resistance in Staphylococcus (7 papers) and Pneumonia and Respiratory Infections (6 papers). Daniel Havlichek is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (9 papers), Antimicrobial Resistance in Staphylococcus (7 papers) and Pneumonia and Respiratory Infections (6 papers). Daniel Havlichek collaborates with scholars based in United States. Daniel Havlichek's co-authors include Gary E. Stein, Louis D. Saravolatz, Charles A. Peloquin, D J Pohlod, Pranatharthi Chandrasekar, Leonard B. Johnson, Chotikorn Khunnawat, George S. Abela, Siddharth Mukerji and Curtis Smith and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Daniel Havlichek

39 papers receiving 619 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Havlichek United States 15 226 212 180 120 71 42 650
J. Salomon France 17 383 1.7× 219 1.0× 88 0.5× 214 1.8× 74 1.0× 69 893
Pedro Llinares Spain 15 470 2.1× 295 1.4× 118 0.7× 170 1.4× 67 0.9× 46 809
Jamie L. Wagner United States 14 204 0.9× 166 0.8× 195 1.1× 185 1.5× 104 1.5× 74 709
S. Harbarth Switzerland 12 237 1.0× 274 1.3× 89 0.5× 164 1.4× 90 1.3× 13 699
Daniel Curcio United States 16 436 1.9× 265 1.3× 158 0.9× 226 1.9× 81 1.1× 50 866
M. Cecilia Di Pentima United States 14 231 1.0× 138 0.7× 137 0.8× 41 0.3× 108 1.5× 33 641
Stéphane Paulus United Kingdom 16 338 1.5× 89 0.4× 138 0.8× 84 0.7× 99 1.4× 41 665
Monica K Sikka United States 13 240 1.1× 224 1.1× 120 0.7× 123 1.0× 69 1.0× 50 615
Dimitra Dimopoulou Greece 17 351 1.6× 233 1.1× 129 0.7× 276 2.3× 85 1.2× 63 898
Nihal Pişkin Türkiye 13 254 1.1× 158 0.7× 144 0.8× 243 2.0× 41 0.6× 27 649

Countries citing papers authored by Daniel Havlichek

Since Specialization
Citations

This map shows the geographic impact of Daniel Havlichek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Havlichek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Havlichek more than expected).

Fields of papers citing papers by Daniel Havlichek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Havlichek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Havlichek. The network helps show where Daniel Havlichek may publish in the future.

Co-authorship network of co-authors of Daniel Havlichek

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Havlichek. A scholar is included among the top collaborators of Daniel Havlichek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Havlichek. Daniel Havlichek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Delekta, Phillip C., Christopher Cooper, Daniel Havlichek, et al.. (2023). The glutathione import system satisfies the Staphylococcus aureus nutrient sulfur requirement and promotes interspecies competition. PLoS Genetics. 19(7). e1010834–e1010834. 5 indexed citations
2.
Havlichek, Daniel, Amrit K. Kamboj, & Cadman L. Leggett. (2022). A Practical Guide to the Evaluation of Small Bowel Bleeding. Mayo Clinic Proceedings. 97(1). 146–153. 3 indexed citations
3.
Cooper, Christopher, et al.. (2021). Long-Acting Lipoglycopeptides for the Treatment of Bone and Joint Infections. Surgical Infections. 22(8). 771–779. 5 indexed citations
4.
Stein, Gary E., Curtis Smith, James M. Kidd, et al.. (2018). Pharmacokinetic and Pharmacodynamic Analysis of Ceftazidime/Avibactam in Critically Ill Patients. Surgical Infections. 20(1). 55–61. 43 indexed citations
5.
Roskos, Steven E., et al.. (2018). Cytomegalovirus infection in immunocompetent adults: Is observation still the best strategy?. IDCases. 14. e00442–e00442. 14 indexed citations
6.
Stein, Gary E., et al.. (2015). A Pharmacokinetic/Pharmacodynamic Analysis of Ceftaroline Prophylaxis in Patients with External Ventricular Drains. Surgical Infections. 16(2). 169–173. 13 indexed citations
7.
Havlichek, Daniel, et al.. (2015). Profile of oritavancin and its potential in the treatment of acute bacterial skin structure infections. Infection and Drug Resistance. 8. 189–189. 14 indexed citations
8.
Chandrasekar, Pranatharthi, Daniel Havlichek, & Leonard B. Johnson. (2014). Infectious Diseases Subspecialty: Declining Demand Challenges and Opportunities. Clinical Infectious Diseases. 59(11). 1593–1598. 41 indexed citations
9.
Stein, Gary E., et al.. (2013). Tissue penetration and antimicrobial activity of standard- and high-dose trimethoprim/sulfamethoxazole and linezolid in patients with diabetic foot infection. Journal of Antimicrobial Chemotherapy. 68(12). 2852–2858. 20 indexed citations
10.
Stein, Gary E., et al.. (2009). Fungicidal activity of anidulafungin in serum from patients does not correlate to its susceptible breakpoint against Candida spp.. Journal of Antimicrobial Chemotherapy. 65(2). 374–376. 5 indexed citations
11.
Khunnawat, Chotikorn, et al.. (2008). Cardiovascular Manifestations in Human Immunodeficiency Virus-Infected Patients. The American Journal of Cardiology. 102(5). 635–642. 58 indexed citations
12.
13.
Kumar, Ashir, Dennis L. Murray, & Daniel Havlichek. (2005). Immunizations for the College Student: a Campus Perspective of an Outbreak and National and International Considerations. Pediatric Clinics of North America. 52(1). 229–241. 18 indexed citations
14.
Stein, Gary E. & Daniel Havlichek. (1998). Newer oral antimicrobials for resistant respiratory tract pathogens. Postgraduate Medicine. 103(6). 67–76. 11 indexed citations
15.
Havlichek, Daniel, et al.. (1997). Age-related hepatitis B seroconversion rates in health care workers. American Journal of Infection Control. 25(5). 418–420. 29 indexed citations
16.
Havlichek, Daniel, et al.. (1997). Disseminated Histoplasmosis in a Patient With Sarcoidosis: A Controversial Relationship and a Diagnostic Dilemma. The American Journal of the Medical Sciences. 313(3). 187–190. 5 indexed citations
17.
Stein, Gary E. & Daniel Havlichek. (1992). The new macrolide antibiotics. Postgraduate Medicine. 92(1). 269–282. 21 indexed citations
18.
Ferenchick, Gary & Daniel Havlichek. (1989). Primary prevention and international travel. Journal of General Internal Medicine. 4(3). 247–258. 5 indexed citations
19.
Havlichek, Daniel, et al.. (1987). Comparison of ciprofloxacin and rifampicin in experimentalLegionella pneumophila pnemnonia. Journal of Antimicrobial Chemotherapy. 20(6). 875–881. 25 indexed citations
20.
Havlichek, Daniel, et al.. (1978). A physiological role for luminal gastrin?. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 83(6). 663–8. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Salomon Breakdown of academic impact, for papers by Pedro Llinares Breakdown of academic impact, for papers by Jamie L. Wagner Breakdown of academic impact, for papers by S. Harbarth Breakdown of academic impact, for papers by Daniel Curcio Breakdown of academic impact, for papers by M. Cecilia Di Pentima Breakdown of academic impact, for papers by Stéphane Paulus Breakdown of academic impact, for papers by Monica K Sikka Breakdown of academic impact, for papers by Dimitra Dimopoulou Breakdown of academic impact, for papers by Nihal Pişkin
Rankless by CCL
2026